Welcome to our dedicated page for Ir-Med news (Ticker: IRME), a resource for investors and traders seeking the latest updates and insights on Ir-Med stock.
Ir-Med Inc (IRME) provides innovative medical technology solutions focused on advanced diagnostic systems and healthcare imaging. This page serves as the definitive source for all official company announcements and market-related developments.
Access real-time updates including earnings reports, product launches, strategic partnerships, and regulatory milestones. Investors and healthcare professionals will find curated press releases detailing IRME's advancements in sensor-based diagnostics and clinical workflow improvements.
Our news collection features verified updates on:
• Medical device innovations
• Clinical trial progress
• Financial performance
• Industry collaborations
Bookmark this page for direct access to primary source materials from Ir-Med Inc. Check regularly for developments impacting the medical technology sector and investment landscape.
IR-MED has published positive results from a usability study of its PressureSafe™ device, performed in collaboration with Clalit, Israel's largest HMO. The study, which included 924 scans on 154 body locations, demonstrated that PressureSafe™ could reduce pressure injuries by 50%. The device achieved 92% sensitivity and 88% specificity in detecting Stage 1 and suspected deep tissue injury pressure injuries. PressureSafe™, which uses AI-driven infra-red spectroscopy, has received FDA listing confirmation. The findings were also presented at the National Pressure Injury Advisory Panel (NPIAP) 2024 Annual Conference.
FAQ
What is the current stock price of Ir-Med (IRME)?
What is the market cap of Ir-Med (IRME)?
